Cost-effectiveness analysis of 3 different drugs in the treatment of type 2 diabetes mellitus / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 355-356, 2012.
Artigo
em Chinês
| WPRIM
| ID: wpr-425146
ABSTRACT
Objective To analyze the cost-effectiveness of the treatment of type 2 diabetes by 3 different drugs.Methods Through the retrospective analysis of 198 cases with T2DM and drug economics,to analyze the costeffectiveness of the Yamo Li(glimepiride),repaglinide(repaglinide) and Avandia(rosiglitazone).Results No significant difference was observed in the total effective rate among the 3 drugs.The cost-effectiveness ratios in Group A,B and C were 2.99,1.43 and 5.76.The cost-effectiveness ratios increments in Group A,B and C were 42.15,18.32 and 214.74.Conclusion Based on individual differences of the patients,doctor should choose the drug with best treatment,lowest price and highest safety.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Avaliação Econômica em Saúde
Idioma:
Chinês
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS